Regulation of a DNA damage response network in glioblastoma

胶质母细胞瘤中 DNA 损伤反应网络的调节

• 批准号: 8577589
• 负责人: ANDY J MINN
• 金额: $ 34.38万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-07-01 至 2018-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8577589
• 关键词: Adult; Affect; Antiviral Response; Binding; Biological; Biological Assay; Breast; Cells; Cellular Assay; Chromatin; Code; Complex; DNA; DNA Damage; DNA Transposable Elements; Disease; Elements; Engineering; Environment; Event; Feedback; Genes; Genetic Transcription; Genome; Glioblastoma; Growth; Head and neck structure; Human; In Vitro; Interferons; Junk DNA; Long-Term Survivors; Lung; Malignant Neoplasms; Malignant neoplasm of brain; Modeling; Mus; Pathway interactions; Patients; Pattern recognition receptor; Phenotype; Property; Prostate; RNA Binding; Radiation; Radiation Tolerance; Regulation; Relative (related person); Repression; Resistance; Role; Signal Pathway; Signal Transduction; Site; Solid Neoplasm; Testing; Transcript; Transplantation; Ubiquitin; Viral; cancer genome; chemotherapy; genetic analysis; genome-wide; genome-wide analysis; human disease; in vivo; insight; melanoma; mouse model; novel; outcome forecast; public health relevance; radiation resistance; research study; response; transcription factor; tumor; viral RNA

DESCRIPTION (provided by applicant): \Recent analysis of cancer genomes suggests that complex phenotypes such as DNA damage resistance may result from perturbations of a biological network. Glioblastoma multiforme (GBM) is the most common and deadly primary adult brain cancer. Unfortunately, the majority of GBM show extreme resistance to radiation (RT) and chemotherapy (chemo). Accordingly, prognosis remains among the lowest of all tumors with a median survival of about one year. Despite this, 5-10% of GBM patients are relative long-term survivors with a median survival of 3-4 years. Through genome-wide analysis, we have discovered that these patients lack a biological network associated with RT/chemo resistance. This network is largely comprised of interferon- stimulated genes (ISGs) and is induced as part of the DNA damage response (DDR). We focus on characterizing the function of key genes in the network that strongly associate with patient survival, are predicted to regulate the network, and/or are genetically or epigenetically inactivated in GBM tumors from long- term survivors. In particular, we focus on signaling pathways that engage the network after DNA damage. Specific Aim 1 explores how the network is activated by interferon-related signaling pathways. For this, we combine unbiased genome-wide approaches and in vitro functional assays. Specific Aim 2 investigates how the network gene ISG15, an ubiquitin-like molecule, acts to negatively feedback on the network to limit the DDR. We characterize how ISG15 influences the chromatin environment to affect signaling events and investigate the importance of this on the DDR. In Specific Aim 3, the biological relevance of the pathways is examined using a GBM mouse model. Here, we investigate the impact of the network on growth and RT response of GBM tumors in vivo. Through these aims, we will gain important insight into how the DDR intersects with the anti-viral response, and how the inactivation of a network of ISGs might contribute to prolonged survival of a subset of GBM patients.

描述（由申请人提供）：\最近对癌症基因组的分析表明，复杂的表型（如DNA损伤抗性）可能是生物网络扰动的结果。多形性胶质母细胞瘤（GBM）是最常见和致命的原发性成人脑癌。不幸的是，大多数GBM对放射（RT）和化疗（chemo）表现出极强的抵抗力。因此，预后仍然是所有肿瘤中最低的，中位生存期约为一年。尽管如此，5-10%的GBM患者是相对长期的生存者，中位生存期为3-4年。通过全基因组分析，我们发现这些患者缺乏与RT/化疗耐药性相关的生物网络。该网络主要由干扰素刺激的基因（ISG）组成，并且作为DNA损伤应答（DDR）的一部分被诱导。我们专注于表征网络中与患者生存密切相关的关键基因的功能，预测其调节网络，和/或在来自长期存活者的GBM肿瘤中遗传或表观遗传失活。特别是，我们专注于DNA损伤后参与网络的信号通路。具体目标1探讨了网络如何被干扰素相关的信号通路激活。为此，我们结合联合收割机无偏全基因组方法和体外功能测定。具体目标2研究了网络基因ISG 15（一种泛素样分子）如何对网络进行负反馈以限制DDR。我们描述了ISG 15如何影响染色质环境以影响信号事件，并研究了这对DDR的重要性。在特定目标3中，使用GBM小鼠模型检查了这些途径的生物学相关性。在这里，我们研究了网络对体内GBM肿瘤生长和RT反应的影响。通过这些目标，我们将获得重要的洞察DDR如何与抗病毒反应交叉，以及ISG网络的失活如何可能有助于GBM患者亚组的生存期延长。